Cargando…
The value of effective public tuberculosis treatment: an analysis of opportunity costs associated with multidrug resistant tuberculosis in Latvia
BACKGROUND: A challenge to effective protection against tuberculosis is to sustain expensive and complex treatment public programs. Potential consequences of program failure include acquired drug resistance, poor patient outcomes, and potentially much higher system costs, however. In contrast, effec...
Autores principales: | Miller, Thaddeus L, Cirule, Andra, Wilson, Fernando A, Holtz, Timothy H, Riekstina, Vija, Cain, Kevin P, Moonan, Patrick K, Leimane, Vaira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637239/ https://www.ncbi.nlm.nih.gov/pubmed/23594422 http://dx.doi.org/10.1186/1478-7547-11-9 |
Ejemplares similares
-
Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia
por: Stagg, Helen R., et al.
Publicado: (2016) -
Multidrug-resistant Tuberculosis Detection, Latvia
por: Skenders, Girts, et al.
Publicado: (2005) -
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
por: Skripconoka, Vija, et al.
Publicado: (2013) -
Problems of HIV positive tuberculosis patients' health care in Latvia
por: Viksna, Ludmila, et al.
Publicado: (2012) -
Pharmacy Practice and Education in Latvia
por: Muceniece, Ruta, et al.
Publicado: (2018)